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background: Fatty acid binding protein 4 (FABP4), which is almost exclusively expressed in adipocytes and macrophages, is regulated by 
peroxisome-proliferator-activated receptor-γ (PPARγ) and contributes to the development of insulin resistance and atherosclerosis in mice. 
Importantly, total or macrophage-specific FABP4 deficiency is protective against atherosclerosis in ApoE-/- mice and FABP4 may be a potential drug 
target in diseases like diabetes and atherosclerosis. However, the FABP4-related pathway in atherosclerosis has not been fully characterized.
methods: Liposomal siRNAs were prepared by using the thin-film hydration method. To determine how FABP4 silencing affects pathways associated 
with atherosclerotic plaque development, we performed reverse phase protein array (RPPA) analysis in mouse macrophage RAW264 cells treated 
with liposomal FABP4 siRNA.
results: Western blot analysis showed that liposomal FABP4 siRNA treatment induced a reduction of 80% compared with control siRNA treatment 
in mouse macrophage RWA264 cells (Figure: A, B). RPPA analysis revealed that the downregulation of FABP4 significantly increased the expression 
of the anti-apoptotic-related proteins BCL2 and BcL-XL and of the autophagy inhibitor protein Beclin-1. Furthermore, the downregulation of FABP4 
significantly inhibited the expression of Bax, a key regulator of apoptosis (Figure: A, C).
conclusion: FABP4 may be a key molecular regulator in atherosclerotic plaque apoptosis and autophagy.
 
